Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
about
Protein Kinase C β: a New Target Therapy to Prevent the Long-Term Atypical Antipsychotic-Induced Weight Gain.The Glasgow antipsychotic side-effects scale for clozapine in inpatients and outpatients with schizophrenia or schizoaffective disorder.Efficacy of Tamsulosin alone versus Tamsulosin Phloroglucinol combination therapy for medical expulsion of lower Ureteral calculi.Influence of dose, gender, and cigarette smoking on clozapine plasma concentrations.
P2860
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年学术文章
@wuu
2016年学术文章
@zh-cn
2016年学术文章
@zh-hans
2016年学术文章
@zh-my
2016年学术文章
@zh-sg
2016年學術文章
@yue
2016年學術文章
@zh
2016年學術文章
@zh-hant
name
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
@en
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
@nl
type
label
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
@en
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
@nl
prefLabel
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
@en
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
@nl
P2860
P50
P1476
Reasons for discontinuing clozapine: A cohort study of patients commencing treatment.
@en
P2093
Marian Hamshere
P2860
P304
P356
10.1016/J.SCHRES.2016.05.002
P407
P50
P577
2016-05-19T00:00:00Z